Brainstem tumors are rare pathologies, brainstem glioblastoma is even rarer. We report three pediatric patients who underwent subtotal tumor resection for brainstem tumors diagnosed as brainstem glioblastoma. The clinical courses and treatment procedures were discussed alongside a comprehensive literature review. Treatment of brainstem high-grade gliomas includes steroids, surgery, radiotherapy, and chemotherapy. However, none of these treatment modalities effectively prolongs survival time. According to literature, the median overall survival of these patients are approximately between 9 to 12 months. Glioblastoma has a poor prognosis in pediatric patients with high-grade brainstem gliomas. Radiotherapy is associated with a decreased risk of mortality at 9 months but not long-term.
ÖZETTiroid kanserleri yıllık endokrin organlara ait kanser ölümlerinin çoğundan sorumludur (1,2) . Bu tümörlerin % 90'ı folliküler hücrelerden köken alırken, geri kalanı kalsitonin üreten C hücreleri veya diğer hücre tiplerinden kaynaklanmıştır. Diferansiye (papiller ve folliküler) tiroid kanserleri yavaş ilerler ve sağ kalımları uzundur. Anaplastik tiroid kanserleri ise tüm insan kanserlerinin en agresif olanı olup, çoğu olguda survi 1 yıldan azdır, ancak ender görü-lür. Kötü diferansiye tiroid kanserleri az anlaşılmış tümör grubu olup, 5 yıllık survi yaklaşık
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.